Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations

International Journal of Radiation Biology

Volumn 90, Issue 1, 2014, Pages 90-94

  Park, Hyojung ^a   Choi, Doo Ho ^a   Noh, Jae Myoung ^a   Huh, Seung Jae ^a   Park, Won ^a   Nam, Seok Jin ^a   Lee, Jeong Eon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

BRCA mutation; Breast cancer; Radiotherapy; Skin toxicity

Indexed keywords

ACUTE TOXICITY; ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; IONIZING RADIATION; KOREA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION THERAPY ONCOLOGY GROUP CRITERIA; RADIOSENSITIVITY; SCORING SYSTEM; SKIN TOXICITY; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ADULT; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; CAUSALITY; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; RADIATION TOLERANCE; RADIODERMATITIS; RADIOTHERAPY, CONFORMAL; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; UBIQUITIN-PROTEIN LIGASES;

EID: 84892767234     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.835504     Document Type: Article

References (15)

1. Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T, Karstens JH. 2003. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late eff ects. Radiotherapy and Oncology 69: 155-160.
2. Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haff ty B, Bergh S, Story M, Geara FB, Brock WA. 2002. Evidence of haplotype insuffi ciency in human cells containing a germline mutation in BRCA1 or BRCA2. International Journal of Cancer 97: 557-561.
3. Chistiakov DA, Voronova NV, Chistiakov PA. 2008. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncologica 47: 809-824.
4. Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K. 2010. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. International Journal of Radiation Oncology, Biology, Physics 76: 1199-1205.
5. Fernando IN, Ford HT, Powles TJ, Ashley S, Glees JP, Torr M, Grafton D, Harmer CL. 1996. Factors aff ecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clinical Oncology (Royal College of Radiologists) 8: 226-233.
6. Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J. 1999. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18: 7334-7342.
7. Gaff ney DK, Brohet RM, Lewis CM, Holden JA, Buys SS, Neuhausen SL, Steele L, Avizonis V, Stewart JR, Cannon-Albright LA. 1998 Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiotherapy and Oncology 47 129-136.
8. Harper JL, Franklin LE, Jenrette JM, Aguero EG. 2004. Skin toxicity during breast irradiation: Pathophysiology and management. Southern Medical Journal 97: 989-993.
9. Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J, Birrell G, Venter D, Southey M, McKay M. 2000. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. International Journal of Radiation Oncology, Biology, Physics 48: 959-965.
10. Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, Sijmons RH, Van der Hout AH, Bauch T, Streff er C, Kampinga HH. 2002. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. International Journal of Radiation Biology 78: 285-295.
11. Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, Gaff ney D, Solin LJ, Nixon A, Garber J, Berg C, Isaacs C, Heimann R, Olopade OI, Haff ty B, Weber BL. 2000. Eff ect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. Journal of Clinical Oncology 18: 3360-3369.
12. Popanda O, Marquardt JU, Chang-Claude J, Schmezer P. 2009. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutation Research 667: 58-69.
13. Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A, Petersen C, Dikomey E. 2012. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiation Oncology 7: 65.
14. Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, Bancroft E, Short S, Gui G, Barr L, Baildam A, Howell A, Royle G, Pierce L, Easton D, Eeles R. 2006. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research 12: 7025-7032.
15. Son BH. 2008. Hereditary breast cancer in Korea: A review of the literature. Journal of Breast cancer 11: 1-9.